Simvastatin 40 MG Oral Tablet
1 INDICATIONS AND USAGE Simvastatin is indicated: To reduce the risk of total mortality by reducing risk of coronary heart disease death, non-fatal myocardial infarction and stroke, and the need for coronary and non-coronary revascularization procedures in adults with established coronary heart disease, cerebrovascular disease, peripheral vascular disease, and/or diabetes, who are at high risk of coronary heart disease events. As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C): In adults with primary hyperlipidemia. In adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to other LDL-C-lowering therapies to reduce LDL-C in adults with homozygous familial hypercholesterolemia (HoFH). As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia. Hypertriglyceridemia. Simvastatin tablets are an HMG-CoA reductase inhibitor indicated: ( 1 ) To reduce the risk of total mortality by reducing risk of coronary heart disease death, non-fatal myocardial infarction and stroke, and the need for coronary and non-coronary revascularization procedures in adults with established coronary heart disease, cerebrovascular disease, peripheral vascular disease, and/or diabetes, who are at high risk of coronary heart disease events. As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C): In adults with primary hyperlipidemia. In adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to other LDL-C-lowering therapies to reduce LDL-C in adults with homozygous familial hypercholesterolemia (HoFH). As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia. Hypertriglyceridemia.
Zydus Pharmaceuticals (USA) Inc.
OVAL PINK ZA22
Related Pills
Simvastatin 10 MG Oral Tablet
Zydus Pharmaceuticals (USA) Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
SIMVASTATIN Tablets USP, 5 mg are white, oval shaped, biconvex, beveled edge, film-coated tablets debossed with "ZA19" on one side and plain on other side and are supplied as follows. NDC 68382-065-06 in bottle of 30 tablets with child-resistant closure NDC 68382-065-14 in bottle of 60 tablets with child-resistant closure NDC 68382-065-16 in bottle of 90 tablets with child-resistant closure NDC 68382-065-05 in bottle of 500 tablets NDC 68382-065-10 in bottle of 1,000 tablets
SIMVASTATIN Tablets USP, 10 mg are pink, oval shaped, biconvex, beveled edge, film-coated tablets debossed with "ZA20" on one side and plain on other side and are supplied as follows. NDC 68382-066-06 in bottle of 30 tablets with child-resistant closure NDC 68382-066-14 in bottle of 60 tablets with child-resistant closure NDC 68382-066-16 in bottle of 90 tablets with child-resistant closure NDC 68382-066-05 in bottle of 500 tablets NDC 68382-066-10 in bottle of 1,000 tablets NDC 68382-066-24 in bottle of 10,000 tablets
SIMVASTATIN Tablets USP, 20 mg are peach, oval shaped, biconvex, beveled edge, film-coated tablets debossed with "ZA21" on one side and plain on other side and are supplied as follows. NDC 68382-067-06 in bottle of 30 tablets with child-resistant closure NDC 68382-067-14 in bottle of 60 tablets with child-resistant closure NDC 68382-067-16 in bottle of 90 tablets with child-resistant closure NDC 68382-067-05 in bottle of 500 tablets NDC 68382-067-10 in bottle of 1,000 tablets NDC 68382-067-24 in bottle of 10,000 tablets
SIMVASTATIN Tablets USP, 40 mg are pink, oval shaped, biconvex, beveled edge, film-coated tablets debossed with "ZA22" on one side and plain on other side and are supplied as follows. NDC 68382-068-06 in bottle of 30 tablets with child-resistant closure NDC 68382-068-14 in bottle of 60 tablets with child-resistant closure NDC 68382-068-16 in bottle of 90 tablets with child-resistant closure NDC 68382-068-05 in bottle of 500 tablets NDC 68382-068-10 in bottle of 1,000 tablets NDC 68382-068-40 in bottle of 5,000 tablets
SIMVASTATIN Tablets USP, 80 mg are white to off-white, capsule shaped, biconvex, film-coated tablets debossed with "ZA23" on one side and plain on other side and are supplied as follows. NDC 68382-069-06 in bottle of 30 tablets with child-resistant closure NDC 68382-069-14 in bottle of 60 tablets with child-resistant closure NDC 68382-069-16 in bottle of 90 tablets with child-resistant closure NDC 68382-069-05 in bottle of 500 tablets NDC 68382-069-10 in bottle of 1,000 tablets Storage Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight container.
More pills like OVAL ZA22